Loading...
Prognostic gene signatures for non-small-cell lung cancer
Resectable non-small-cell lung cancer (NSCLC) patients have poor prognosis, with 30–50% relapsing within 5 years. Current staging criteria do not fully capture the complexity of this disease. Survival could be improved by identification of those early-stage patients who are most likely to benefit fr...
Na minha lista:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
National Academy of Sciences
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2636731/ https://ncbi.nlm.nih.gov/pubmed/19196983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0809444106 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|